Highlights Newsletter 4

This newsletter presents you the following key sessions:

1. Podcast with Prof. Sara Hurvitz about treatment with trastuzumab deruxtecan vs. trastuzumab emtansine in
    HER2-positive metastatic breast cancer: Updated results from DESTINY-Breast03

2. Podcast with Dr. Judy Boughey about the impact of breast conservation therapy on local recurrence in
    patients with multiple ipsilateral breast cancer: Results from the Alliance trial

3. Podcast with Prof. Mafalda Oliveira about different doses of camizestrant monotherapy vs. fulvestrant in
    advanced ER+/ HER2- breast cancer: Results from SERENA-2

4. Podcast with Prof. Erica Mayer about fulvestrant, palbociclib, and avelumab treatment combinations for
    endocrine pre-treated ER+/HER2- metastatic breast cancer: Results from the PACE trial